Evidence map›Paper›PMID 40791607›Full record

ArticleResearch and practice in thrombosis and haemostasis2025

Differences in risk factors between all-cause and pulmonary embolism-related death in acute pulmonary embolism: insights from the COMMAND VTE registry-2.

Soichiro Kobayashi, Yoshito Ogihara, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Yuji Nishimoto, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda and 28 more

Abstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Soichiro KobayashiDepartment of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan.
Yoshito OgiharaDepartment of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan.
Yugo YamashitaDepartment of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takeshi MorimotoDepartment of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.
Ryuki ChataniDepartment of Cardiovascular Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
Kazuhisa KanedaDepartment of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yuji NishimotoDepartment of Cardiology, Toyonaka Municipal Hospital, Osaka, Japan.
Nobutaka IkedaDivision of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
Yohei KobayashiDepartment of Cardiovascular Center, Osaka Red Cross Hospital, Osaka, Japan.
Satoshi IkedaDepartment of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Kitae KimDepartment of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
Moriaki InokoDepartment of Cardiovascular Center, Medical Research Institute Kitano Hospital, Osaka, Japan.
Toru TakaseDepartment of Cardiology, Kinki University Hospital, Osaka, Japan.
Shuhei TsujiDepartment of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
Maki OiDepartment of Cardiology, Japanese Red Cross Otsu Hospital, Otsu, Japan.
Takuma TakadaDepartment of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.
Kazunori OtsuiDepartment of General Internal Medicine, Kobe University Hospital, Kobe, Japan.
Jiro SakamotoDepartment of Cardiology, Tenri Hospital, Tenri, Japan.
Takeshi InoueDepartment of Cardiology, Shiga General Hospital, Moriyama, Japan.
Shunsuke UsamiDepartment of Cardiology, Kansai Electric Power Hospital, Osaka, Japan.
Po-Min ChenDepartment of Cardiology, Osaka Saiseikai Noe Hospital, Osaka, Japan.
Kiyonori TogiDivision of Cardiology, Nara Hospital, Kinki University Faculty of Medicine, Ikoma, Japan.
Norimichi KoitabashiDepartment of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
Seiichi HiramoriDepartment of Cardiology, Kokura Memorial Hospital, Kokura, Japan.
Kosuke DoiDepartment of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Hiroshi MabuchiDepartment of Cardiology, Koto Memorial Hospital, Higashiomi, Japan.
Yoshiaki TsuyukiDivision of Cardiology, Shimada General Medical Center, Shimada, Japan.
Koichiro MurataDepartment of Cardiology, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
Kensuke TakabayashiDepartment of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan.
Hisato NakaiDepartment of Cardiovascular Medicine, Sugita Genpaku Memorial Obama Municipal Hospital, Obama, Japan.
Daisuke SuetaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Wataru ShioyamaDepartment of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan.
Tomohiro DohkeDivision of Cardiology, Kohka Public Hospital, Koka, Japan.
Toru SatoDepartment of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan.
Ryusuke NishikawaDepartment of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takeshi KimuraDepartment of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan.
Kaoru DohiDepartment of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan.
COMMAND VTE Registry-2 Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accurate risk prediction of early mortality, particularly pulmonary embolism (PE)-related death, in patients with acute PE has become more important for selecting optimal management strategies. Objectives: To evaluate the cumulative 30-day incidence of and risk factors for all-cause and PE-related death within 30 days. Methods: In the COMMAND VTE Registry-2, which enrolled symptomatic patients with venous thromboembolism at 31 centers in Japan, we analyzed 2035 patients with acute PE. Results: The cumulative 30-day incidence of all-cause and PE-related death was 6.4% and 3.4%, respectively. Independent risk factors for all-cause and PE-related death were age >80 years (hazard ratio [HR], 2.43; 95% CI, 1.45-4.08; Conclusion: We identified several independent risk factors for PE-related death within 30 days, which differed from those of all-cause death. Risk factors specifically for PE-related death may be useful in decision-making for optimal treatment strategies for acute PE.

Indexed as

anticoagulantsfactor Xa inhibitorsmortalitypulmonary embolismrisk assessment

Identifiers

PMID40791607
PMCPMC12336812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.